Comparative Pharmacology
Head-to-head clinical analysis: DEXTROSE 5 SODIUM CHLORIDE 0 33 AND POTASSIUM CHLORIDE 0 15 IN PLASTIC CONTAINER versus MAGNESIUM SULFATE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: DEXTROSE 5 SODIUM CHLORIDE 0 33 AND POTASSIUM CHLORIDE 0 15 IN PLASTIC CONTAINER versus MAGNESIUM SULFATE.
DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 0.15% IN PLASTIC CONTAINER vs MAGNESIUM SULFATE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Dextrose provides a source of calories and carbohydrate for metabolism; sodium and chloride are major electrolytes that maintain osmotic pressure and acid-base balance; potassium is essential for nerve impulse transmission, muscle contraction, and cardiac function.
Magnesium sulfate acts as a physiological calcium channel blocker. It inhibits calcium influx into presynaptic nerve terminals, reducing acetylcholine release at the neuromuscular junction and decreasing muscle contraction. It also antagonizes NMDA receptors and stabilizes neuronal membranes.
Intravenous infusion. Dose depends on patient's fluid, electrolyte, and caloric needs. Typical adult: 1000-2000 mL/day at 1-4 mL/min. Rate should not exceed 10 mL/min. Potassium content is 20 mEq/L; maximum potassium infusion rate is 10-20 mEq/h, not to exceed 240 mEq/day.
IV: Loading dose 4-6 g over 20-30 minutes, followed by maintenance infusion 1-2 g/hour for seizure prophylaxis in severe preeclampsia/eclampsia. IM: 4-8 g deep IM initially, then 4 g every 4 hours as needed.
None Documented
None Documented
Glucose: 1.5-2.5 hours for exogenous glucose clearance. Potassium: terminal half-life 7-12 hours in normal renal function. Sodium: no defined half-life; body content regulated by renal excretion.
Terminal elimination half-life approximately 4-6 hours in patients with normal renal function; prolonged to 12-24 hours or more in renal impairment, necessitating dose adjustment
Renal: D-glucose is completely reabsorbed under normal conditions; excess is excreted unchanged. Potassium is primarily excreted by the kidneys (90%), with minor fecal (10%) loss. Sodium is predominantly excreted renally (95%), with small amounts via sweat and feces (5%). Chloride follows sodium excretion.
Primarily renal (90-95% as unchanged drug); minor biliary/fecal (<5%)
Category A/B
Category C
Electrolyte
Electrolyte